2-(tert-butyl)-4-methylnitrobenzene

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(tert-butyl)-4-methylnitrobenzene
• 英文别名: 4-Nitro-5-tert.-butyl-toluol；2-Tert-butyl-4-methyl-1-nitrobenzene
• 化学式: C₁₁H₁₅NO₂
• 分子量: 193.246
• InChiKey: BMEKQBJOPVMFKI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  45.8
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(tert-butyl)-4-methylnitrobenzene 、 Diphenylphosphine oxide 在 dirhodium tetraacetate 作用下， 以 甲苯 为溶剂， 反应 7.0h， 以52%的产率得到6-(t-butyl)-2-(diphenylphosphinoyloxy)-4-methylaniline
  参考文献：
  名称：

  Synthesis of o-(diphenylphosphinoyloxy)anilines by the rhodium-catalyzed reaction of nitroarenes and diphenylphosphine oxide

  摘要：

  A rhodium complex Rh(2)(OAc)(4) catalyzed the reaction of nitrobenzenes and diphenylphosphine oxide HP(=O)Ph(2) giving o-(diphenylphosphinoyloxy)anilines predominantly, which were accompanied by small amounts of the p-isomers. Nitorobenzenes possessing a bulky o-substituent, particularly o-(t-butyl)nitrobenzenes, underwent the reaction in high yields. The reaction is considered to involve the reductive formation of O-phosphinoyl-N-arylhydroxyamines from nitrobenzenes, and o-phosphinoyloxylation by the rearrangement. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2010.04.029
• 作为产物：
  描述：

  3-叔丁基甲苯 在 nitronium tetrafluoborate 作用下， 以 环丁砜 为溶剂， 生成 2-(tert-butyl)-4-methylnitrobenzene
  参考文献：
  名称：

  Aromatic Substitution. XX. Intact and Dealkylating Nitration of Propylated and Butylated Alkylbenzenes with Nitronium Tetronium Tetrafluoroborate

  摘要：

  DOI：

  10.1021/ja01060a020

文献信息

• 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY
  申请人：FOULON Loic

  公开号：US20100069384A1

  公开（公告）日：2010-03-18

  The present invention relates to derivatives of 5-alkyloxy-indolin-2-one, their method of production and their therapeutic applications. These novel derivatives have affinity and selectivity for the V 2 receptors of vasopressin (“V 2 receptors”) and can therefore constitute active principles of pharmaceutical compositions.

  本发明涉及5-烷氧基吲哚啉-2-酮的衍生物，其生产方法及其治疗应用。这些新颖的衍生物具有对加压素V2受体（“V2受体”）的亲和力和选择性，因此可以构成药物组合物的活性成分。
• Luciferin Derivatives from Bicyclic Reactants and Aminothiol Derivatives and Methods of Use Thereof
  申请人：The Regents of the University of California

  公开号：US20130287699A1

  公开（公告）日：2013-10-31

  The present disclosure features a condensation reaction and a luciferin-unmasking reaction that can be carried out under physiological conditions. In general, the condensation reaction involves reacting a bicyclic reactant with an aminothiol derivative, generating a luciferin or luciferin derivative. A luciferin can provide detectable luminescence. A luciferin derivative can be unmasked to provide detectable luminescence in a luciferin-unmasking reaction. The present disclosure provides bicyclic reactants and aminothiol derivatives suitable for use in the condensation reaction. The condensation and luciferin-unmasking reactions find use in a variety of applications, which are also provided.

  本公开涉及一种可以在生理条件下进行的缩合反应和发光素暴露反应。通常，缩合反应涉及将双环反应物与氨基硫醇衍生物反应，生成发光素或发光素衍生物。发光素可以提供可检测的发光。发光素衍生物可以在发光素暴露反应中被揭示出来，提供可检测的发光。本公开提供适用于缩合反应的双环反应物和氨基硫醇衍生物。缩合和发光素暴露反应在各种应用中有用，这些应用也被提供。
• TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS
  申请人：BROWN James

  公开号：US20130158034A1

  公开（公告）日：2013-06-20

  Compounds of Formula I are useful as antagonists of TRPM8. Such compounds are useful in treating a number of TRPM8 mediated disorders and conditions and may be used to prepare medicaments and pharmaceutical compositions useful for treating such disorders and conditions. Examples of such disorders include, but are not limited to, migraines and neuropathic pain. Compounds of Formula I have the following structure: where the definitions of the variables are provided herein.

  式I的化合物是TRPM8拮抗剂，对于治疗许多TRPM8介导的疾病和症状有用，并可用于制备治疗此类疾病和症状的药物和制剂。此类疾病的例子包括但不限于偏头痛和神经病性疼痛。式I的化合物具有以下结构：其中变量的定义在此提供。
• LUCIFERIN DERIVATIVES FROM BICYCLIC REACTANTS AND AMINOTHIOL DERIVATIVES AND METHODS OF USE THEREOF
  申请人：The Regents of the University of California

  公开号：US20160015835A1

  公开（公告）日：2016-01-21

  The present disclosure features a condensation reaction and a luciferin-unmasking reaction that can be carried out under physiological conditions. In general, the condensation reaction involves reacting a bicyclic reactant with an aminothiol derivative, generating a luciferin or luciferin derivative. A luciferin can provide detectable luminescence. A luciferin derivative can be unmasked to provide detectable luminescence in a luciferin-unmasking reaction. The present disclosure provides bicyclic reactants and aminothiol derivatives suitable for use in the condensation reaction. The condensation and luciferin-unmasking reactions find use in a variety of applications, which are also provided.

  本公开涉及一种可以在生理条件下进行的缩合反应和发光素解掩蔽反应。一般而言，缩合反应涉及将双环反应物与氨硫醇衍生物反应，生成发光素或发光素衍生物。发光素可以提供可检测的发光。发光素衍生物可以在发光素解掩蔽反应中被揭示出来，提供可检测的发光。本公开提供了适用于缩合反应的双环反应物和氨硫醇衍生物。缩合和发光素解掩蔽反应在多种应用中发挥作用，这些应用也被提供。
• US8778941B2
  申请人：——

  公开号：US8778941B2

  公开（公告）日：2014-07-15